Chief Strategy Officer Radiopharmaceuticals

ARTO; Frankfurt; Vor Ort; EUR 120.000 - 180.000; Vollzeit

Zusammenfassung

An established industry player in Nuclear Medicine is seeking a Chief Strategic Officer to drive market access and sales growth across Europe. This pivotal role involves developing and executing strategies to capture significant market share, establishing key relationships with payers, and leading a commercial sales strategy aligned with ambitious revenue targets. If you are a seasoned executive with a passion for market access in the radiopharmaceutical space, this is your opportunity to make a substantial impact in a rapidly evolving market.

Qualifikationen

• Proven experience in senior Sales or Market Access leadership roles.
• Deep knowledge of European radiopharmaceuticals and nuclear medicine markets.

Aufgaben

• Lead the go-to-market strategy for the European radiopharmaceutical market.
• Establish relationships with payers and reimbursement agencies across Europe.

Kenntnisse

Sales Leadership

Market Access Strategy

Competitive Analysis

Commercial Acumen

Negotiation Skills

Ausbildung

Master's in Business Administration

PhD in Life Sciences

Jobbeschreibung

Job Title : Chief Strategic Officer (CSO) – Market Access & Sales

Location : Europe (Preference for DACH region)

Company Overview :

We are a leading Nuclear Medicine & Radiopharmaceutical company , driving the commercialization of a first-in-class, next-generation Phase III isotope . With a successfully marketed product and strong investor backing, we are now seeking a Chief Strategic Officer (CSO) to spearhead market share expansion and sales growth across Europe , with a primary focus on achieving a 25% market share in the region.

Key Responsibilities :

Market Share Growth & Competitive Strategy

• Lead the go-to-market strategy to secure a dominant position in the European radiopharmaceutical market.
• Conduct market mapping and competitive analysis to identify key players, industry trends, and untapped opportunities.
• Define and execute a roadmap to capture 25% market share , ensuring aggressive but sustainable expansion.
• Develop and present data-driven commercial strategies to the CEO and executive team to optimize market penetration.

Market Access & Pricing Leadership

• Establish and manage relationships with payers and reimbursement agencies across Europe , with a core focus on the DACH region .
• Drive pricing and reimbursement negotiations , ensuring optimal access and uptake of our product portfolio.
• Form and lead an advisory board of key decision-makers , including regulatory and industry experts, to navigate complex market entry challenges.

Sales Expansion & Business Development

• Develop and scale a commercial sales strategy that aligns with revenue and market share targets.
• Identify and execute B2B partnerships , securing distribution channels to accelerate adoption.
• Spearhead commercial team growth, with a planned expansion of the European sales team in 2026 .

Cross-Functional & Executive Leadership

• Align the company’s European commercial strategy with global business objectives.
• Collaborate with regulatory, medical affairs, and corporate teams to drive strategic initiatives.
• Act as the commercial face of the company , engaging with key stakeholders and industry bodies to solidify our market presence.

Key Qualifications & Experience :

• Proven experience in a senior Sales or Market Access leadership role , with a track record of delivering market share growth .
• Deep knowledge of European radiopharmaceuticals and nuclear medicine markets , including payer dynamics and regulatory frameworks.
• Strong commercial acumen , with the ability to develop and execute high-impact market entry strategies .
• Executive leadership experience, with the ability to scale sales teams and drive revenue growth.
• Experience working within a clinical-stage or commercial-stage biotech / pharmaceutical environment .

If you are a highly driven C-suite executive with a passion for market access and sales within the radiopharmaceutical space, we invite you to apply.